Profile
NUWE ABT BSX-PA SYK MDT BSX
Company Name Nuwellis, Inc. Abbott Laboratories Boston Scientific Corporation Stryker Corporation Medtronic plc Boston Scientific Corporation
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $2.36M $192.90B $175.45B $137.02B $131.98B $113.11B
Employees 0.04K 114.00K 45.00K 53.00K 95.00K 53.00K
CEO Neil Ayotte Robert Ford Michael F. Mahoney Kevin A. Lobo Geoffrey Straub Martha Michael F. Mahoney
Ratings
NUWE ABT BSX-PA SYK MDT BSX
Quant Rating Score 2 2 3 3 1
Quant Rating Sell Sell Neutral Neutral Strong Sell
Trading
NUWE ABT BSX-PA SYK MDT BSX
Last Close $2.452 $130.03 $122.18 $360.13 $96.28 $101.76
High 52 $16.1 $140.22 $122.18 $403.53 $98.43 $108.14
Low 52 $0.2 $111.1 $122.18 $337.28 $79.61 $88.03
Price vs. 52 Week High -84.77 % -7.27 % 0 % -10.76 % -2.18 % -5.9 %
Price vs. 52 Week Low 1126 % 17.04 % 0 % 6.77 % 20.94 % 15.6 %
Total Return
NUWE ABT BSX-PA SYK MDT BSX
1 Month Return -28.72 % 1.16 % 0 % -3.82 % 0.52 % 2.54 %
3 Month Return -61.08 % -0.18 % 0 % -5.68 % 3.74 % -1.25 %
6 Month Return 160.66 % -3.54 % 0 % -8.65 % 11.38 % -4.04 %
9 Month Return 87.18 % -0.12 % 0 % -6.61 % 11.86 % -3.41 %
YTD Return 120.9 % 14.96 % 0 % 0.02 % 20.53 % 13.93 %
1 Year Return 82.99 % 11.01 % 0 % -7.35 % 13.27 % 12.65 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
NUWE ABT BSX-PA SYK MDT BSX
Dividend Yield Percentage (TTM) - 2.17 % - 0.95 % 2.75 % -
Dividend Paid and Capex Coverage Ration (TTM) -74.27 % 1.46 % 5.44 % 2.47 % 1.29 % 5.44 %
Dividend Per Share (TTM) - 2.4 % - 3.4 % 2.83 % -
Payout Ratio (TTM) - 61.99 % - 39.56 % 75.84 % -
Profitability
NUWE ABT BSX-PA SYK MDT BSX
Gross Profit Margin TTM 60.91 % 55.51 % 65.05 % 63.54 % 62.27 % 69.01 %
Return on Assets TTM -207.5 % 7.75 % 6.53 % 6.78 % 5.22 % 6.77 %
Return on Equity TTM -1308.35 % 13.18 % 12.42 % 15.04 % 9.83 % 12.87 %
Return on Capital Employed TTM -247.65 % 11.56 % 8.97 % 14.07 % 7.63 % 10.62 %
Net Income Per EBT TTM 100.04 % 77.06 % 85.26 % 71.91 % 83.61 % 85.38 %
EBT Per Ebit TTM 149.87 % 105.19 % 97.5 % 80.09 % 91.74 % 85.24 %
EBIT Per Revenue TTM -135.28 % 18.16 % 17.33 % 22.44 % 17.87 % 19.78 %
Cash Flow To Debt Ratio TTM -2424.02 % 70.47 % 38.4 % 33.95 % 24.44 % 38.4 %
Receivables Turnover TTM 7.16 4.26 6.84 6.22 5.44 7.1
Payables Turnover TTM - 4.78 6.75 - 5.08 6.21
Inventory Turnover TTM 1.46 2.94 2.32 1.72 2.13 2.13
Fixed Asset Turnover TTM 1070.51 % 385.33 % 451.15 % 647.99 % 485.18 % 468.06 %
Asset Turnover TTM 102.3 % 52.66 % 45.31 % 52.5 % 38.05 % 47.01 %
Operating Cash Flow Per Share TTM -11.1 5.22 3.12 13.19 5.55 3.12
Free Cash Flow Per Share TTM -11.25 3.96 2.55 11.2 4.06 2.55
Cash Per Share TTM 369.92 % 442.64 % 86.05 % 1071.9 % 649.63 % 85.99 %
Operating Cash Flow Sales Ratio TTM -113.66 % 20.57 % 23.91 % 20.08 % 20.46 % 23.04 %
Free Cash Flow Operating Cash Flow Ratio TTM 101.35 % 75.85 % 81.6 % 84.91 % 73.19 % 81.6 %
Cash Flow Coverage Ratios TTM -2424.02 % 70.47 % 38.4 % 33.95 % 24.44 % 38.4 %
Price To Free Cash Flows Ratio TTM -0.25 27.89 35.99 31.99 25.35 29.96
Price To Operating Cash Flows Ratio TTM -0.24 21.23 29.35 27.17 18.54 24.45
Price Cash Flow Ratio TTM -0.24 21.23 29.35 27.17 18.54 24.45
Income Statement (TTM)
NUWE ABT BSX-PA SYK MDT BSX
Revenue $0.01B $44.33B $20.07B $25.12B $33.54B $20.07B
Gross Profit $0.01B $24.61B $13.85B $15.43B $21.91B $13.85B
Gross Profit Ratio 66.66% 55.51% 69.01% 61.44% 65.32% 69.01%
EBITDA $-0.01B $11.33B $3.73B $5.69B $9.22B $3.73B
Net Income $-0.01B $6.52B $2.89B $3.25B $4.66B $2.89B
EPS Diluted -8 3.72 1.94 8.4 3.61 1.94
Balance Sheet (MRQ)
NUWE ABT BSX-PA SYK MDT BSX
Long Term Debt $0B $13.52B $9.37B $14.86B $25.64B $9.37B
Total Liabilities $0B $33.51B $17.39B $25.42B $43.42B $17.39B
Total Equity $0.01B $47.9B $22B $22.42B $48.26B $22B
Total Investments $0B $1.24B $0.56B $0.09B $6.75B $0.56B
Total Debt $0B $15.28B $11.15B $14.86B $28.52B $11.15B
Total Assets $0.01B $81.41B $39.4B $47.84B $91.68B $39.4B
Cash Flow Statement (TTM)
NUWE ABT BSX-PA SYK MDT BSX
Net Income $-0.01B $13.4B $1.85B $3.25B $4.69B $1.85B
Inventory $0B $-0.06B $-0.23B $0B $-0.29B $-0.23B
Dividends Paid $0B $-3.84B $0B $-1.28B $-3.59B $0B
Operating Cash Flow $-0.01B $8.56B $3.44B $5.04B $7.04B $3.44B
Capital Expenditure $-0B $-2.21B $-0.79B $-0.76B $-1.86B $-0.79B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 112.35
ADGM Adagio Medical Holdings, Inc. 1.01
AEMD Aethlon Medical, Inc. 2.15
AFIB Acutus Medical, Inc. 0.0002
AHCO AdaptHealth Corp. 10.64
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 196.4
ALUR Allurion Technologies Inc. 1.13
AMIX Autonomix Medical, Inc. Common Stock 0.4103
ANIK Anika Therapeutics, Inc. 10.34
AORT Artivion, Inc. 40.375
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 4.02
ARAY Accuray Incorporated 0.5547
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 13.905
AVNS Avanos Medical, Inc. 14.71
AVR Anteris Technologies Global Corp. Common Stock 5.77
AXDX Accelerate Diagnostics, Inc. 0.034
ETFs With Exposure to NUWE
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0 219.39
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 166.55
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 166.56
VEMPX Vanguard Extended Market Index InstlPlus 0 411.02
Unlock